Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Volume-regulated anion channel subunit LRRC8D (LRRC8D) is a pore-forming component of the volume-regulated anion channel (VRAC), which controls cell volume by mediating the flux of chloride ions and diverse organic osmolytes in response to cell swelling[1][2][3][4]. LRRC8D must heteromerize with LRRC8A and other LRRC8 subunits (LRRC8B–E) to form functional VRACs, with the exact subunit composition conferring permeability to a broad spectrum of organic substrates—including amino acids and drugs like cisplatin[1][4]. Structural studies show LRRC8D-containing channels have a wider extracellular pore constriction compared to LRRC8A, suggesting a basis for their more permissive substrate selectivity[1][2][3]. LRRC8D is essential for the cellular entry of certain chemotherapeutics and antibiotics, making its expression a key factor in drug sensitivity, especially in tumors where downregulation of LRRC8D leads to chemoresistance[1].
Drug entry through VRAC when LRRC8D is present in heteromers (increases uptake of certain chemotherapeutic and antibiotic agents; loss reduces cellular uptake and leads to resistance)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Volume-regulated anion channel subunit LRRC8D (LRRC8D).